RecruitingNCT07372820

METABolic Deterioration in HTX Determines Outcomes

METAB-HTX: Prospective, Longitudinal Cohort Study Evaluationg Cardiac and Systemic Metabolism After Heart Transplantation

Sponsor

Heinrich-Heine University, Duesseldorf

Enrollment

270 participants

Start Date

Jul 24, 2025

Study Type

OBSERVATIONAL

Conditions

Heart Transplantation

Summary

METAB-HTX is a prospective, longitudinal cohort study evaluating cardiac and systemic metabolism in heart transplant recipients.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating how metabolic changes — such as shifts in blood sugar, cholesterol, and body weight — after a heart transplant affect long-term health outcomes, helping doctors better understand and manage complications in heart transplant patients. **You may be eligible if...** - You are 18 years or older - You are scheduled to undergo a heart transplant, or you have already had one - You are willing to provide informed consent **You may NOT be eligible if...** - You are unwilling or unable to give informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.